Vassilios Sikavitsas to Cell Line, Tumor
This is a "connection" page, showing publications Vassilios Sikavitsas has written about Cell Line, Tumor.
Connection Strength
0.048
-
Antitumor Synergism and Enhanced Survival with a Tumor Vasculature-Targeted Enzyme Prodrug System, Rapamycin, and Cyclophosphamide. Mol Cancer Ther. 2017 09; 16(9):1855-1865.
Score: 0.027
-
Antitumor activity of an enzyme prodrug therapy targeted to the breast tumor vasculature. Cancer Invest. 2013 Oct; 31(8):505-10.
Score: 0.021